Literature DB >> 7977302

Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S.

P A Lane1, J L O'Connell, R A Marlar.   

Abstract

Plasma levels of free protein S, a vitamin K-dependent anticoagulant, are decreased in persons with sickle cell anemia, but the etiology of the low levels is unknown. Protein S binds to phosphatidylserine-containing phospholipids in a calcium-dependent manner. Other studies have indicated that phosphatidylserine may be abnormally present on the outer surface of the membrane lipid bilayer of sickle cells and of the spectrin-depleted vesicles they shed in vivo. We studied the binding of purified, radiolabeled protein S to spectrin-depleted erythrocyte membrane vesicles and to density-separated fractions of sickle and normal erythrocytes. Calcium-dependent binding of protein S occurred with vesicles and with well-aerated dense irreversibly sickled cells, but not with well-aerated sickle discocytes or with normal erythrocytes. These data provide further evidence that phosphatidylserine is abnormally present on the outer surface of spectrin-depleted vesicles and of irreversibly sickled cells. In addition, protein S binding to such sickle membranes in vivo may be responsible, in part, for the decreased levels of free protein S in sickle cell plasma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977302     DOI: 10.1002/ajh.2830470409

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

Review 1.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 3.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

4.  Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Authors:  Ruzica Livaja Koshiar; Sofia Somajo; Eva Norström; Björn Dahlbäck
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 5.  The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Gregory J Kato
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

6.  Severity of Anaemia Has Corresponding Effects on Coagulation Parameters of Sickle Cell Disease Patients.

Authors:  Samuel Antwi-Baffour; Ransford Kyeremeh; Lawrence Annison
Journal:  Diseases       Date:  2019-12-17

Review 7.  Targeting neoantigens for cancer immunotherapy.

Authors:  Xuan Zhao; Xiaoxin Pan; Yi Wang; Yi Zhang
Journal:  Biomark Res       Date:  2021-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.